Page last updated: 2024-11-12

dihydrolycorine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID11876135
CHEMBL ID583061
SCHEMBL ID21578274
MeSH IDM0060274

Synonyms (22)

Synonym
z7n4s72301 ,
6271-21-2
unii-z7n4s72301
galanthan-1,2-diol, 9,10-(methylenebis(oxy))-, (1alpha,2beta)-
dihydrolycorine
CHEMBL583061
S3285
(1s,2s,3ar,12bs,12cr)-2,3,3a,4,5,7,12b,12c-octahydro-1h-[1,3]dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridine-1,2-diol
AC-34198
Q-100723
.alpha.-dihydrolycorine
1h-(1,3)dioxolo(4,5-j)pyrrolo(3,2,1-de)phenanthridine-1,2-diol, 2,3,3a,4,5,7,12b,12c-octahydro-, (1s,2s,3ar,12bs,12cr)-
dihydrolycorine, (+)-
SCHEMBL21578274
AKOS030573518
mfcd09953807
Q27295119
HY-N2403
CS-0022605
(1s,15r,17s,18s,19r)-5,7-dioxa-12-azapentacyclo[10.6.1.02,10.04,8.015,19]nonadeca-2,4(8),9-triene-17,18-diol
MS-24132
DTXSID701346488

Research Excerpts

Overview

Dihydrolycorine-HCL(DL) is a derivative of lycorine, an alkaloid isolated from Lycoris radiata Herb.

ExcerptReferenceRelevance
"Dihydrolycorine-HCL(DL) is a derivative of lycorine, an alkaloid isolated from Lycoris radiata Herb. "( [Hypotensive effect of dihydrolycorine].
Chen, BY; Du, ZH; Hong, SH; Hu, CJ; Ma, GE; Zeng, FD, 1993
)
2.04
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (12)

Assay IDTitleYearJournalArticle
AID438127Growth inhibition of proapoptotic stimuli-sensitive mouse B16F10 cells after 72 hrs by MTT assay2009Journal of medicinal chemistry, Oct-22, Volume: 52, Issue:20
Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight.
AID1578097Antitrypanosomal activity against Leishmania donovani2019Bioorganic & medicinal chemistry letters, 10-15, Volume: 29, Issue:20
Antiprotozoal alkaloid principles of the plant family Amaryllidaceae.
AID1578093Antitrypanosomal activity against Trypanosoma cruzi2019Bioorganic & medicinal chemistry letters, 10-15, Volume: 29, Issue:20
Antiprotozoal alkaloid principles of the plant family Amaryllidaceae.
AID1578098Antitrypanosomal activity against Trypanosoma brucei rhodesiense2019Bioorganic & medicinal chemistry letters, 10-15, Volume: 29, Issue:20
Antiprotozoal alkaloid principles of the plant family Amaryllidaceae.
AID438120Growth inhibition of proapoptotic stimuli-resistant human OE21 cells after 72 hrs by MTT assay2009Journal of medicinal chemistry, Oct-22, Volume: 52, Issue:20
Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight.
AID438126Growth inhibition of proapoptotic stimuli-resistant human SK-MEL-28 cells after 72 hrs by MTT assay2009Journal of medicinal chemistry, Oct-22, Volume: 52, Issue:20
Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight.
AID1578104Selectivity index, ratio of IC50 for Trypanosoma brucei rhodesiense to IC50 for human KB cells2019Bioorganic & medicinal chemistry letters, 10-15, Volume: 29, Issue:20
Antiprotozoal alkaloid principles of the plant family Amaryllidaceae.
AID438124Growth inhibition of proapoptotic stimuli-sensitive human Hs683 cells after 72 hrs by MTT assay2009Journal of medicinal chemistry, Oct-22, Volume: 52, Issue:20
Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight.
AID438119Growth inhibition of proapoptotic stimuli-resistant human A549 cells after 72 hrs by MTT assay2009Journal of medicinal chemistry, Oct-22, Volume: 52, Issue:20
Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight.
AID1578102Cytotoxicity against rat L6 cells assessed as reduction in cell viability2019Bioorganic & medicinal chemistry letters, 10-15, Volume: 29, Issue:20
Antiprotozoal alkaloid principles of the plant family Amaryllidaceae.
AID438125Growth inhibition of proapoptotic stimuli-resistant human U373 cells after 72 hrs by MTT assay2009Journal of medicinal chemistry, Oct-22, Volume: 52, Issue:20
Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight.
AID1578103Cytotoxicity against human KB cells assessed as reduction in cell viability2019Bioorganic & medicinal chemistry letters, 10-15, Volume: 29, Issue:20
Antiprotozoal alkaloid principles of the plant family Amaryllidaceae.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 13.01

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index13.01 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (13.01)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]